华领医药收到8亿元里程碑付款 宝尊电商三季度净亏损同比收窄逾两成|港股11月21日公告精选

Hualing Pharmaceutical received a milestone of 800 million yuan, and Baozun E-commerce's net loss in the third quarter narrowed by more than 20% year-on-year | Selected Hong Kong Stock Announcements on November 21 ·  11/22/2023 21:28

① Hualing Pharmaceutical received a milestone payment of 800 million yuan. What product pipeline progress is involved? ② Baozun e-commerce's net loss in the third quarter narrowed year-on-year. How was the revenue performance?

Financial News Agency, November 22 (Editor Feng Yi) Financial Association brings you today's important Hong Kong stock announcements

1) Company news

Hualing Pharmaceutical-B (02552): Hualing Shanghai has received a milestone payment of RMB 800 million from Bayer relating to the achievement of an important milestone in Huatangning's development.

Baozun E-Commerce-W (09991.HK): Total net revenue for the third quarter was 1,8236 million yuan, up 4.7% year on year; net loss was 126 million yuan, narrowing by about 25.12% year on year.

China Reinsurance (01508.HK): In the first 10 months, it obtained original premium income of 42.187 billion yuan through China Land Financial Insurance, an increase of 8.6% over the previous year.

Lianyirong Technology-W (09959.HK): Plans to sell 19.608% of Sinopharm Ronghui (Shanghai) commercial factoring shares for 112 million yuan.

Bank of China Financial Leasing (01606.HK): Plans to lease offshore wind power equipment assets of 1.1 billion yuan from Xinneng Haili.

Cinda Biotech (01801.HK): The State Drug Administration has accepted a new drug marketing application for telaletinib, a ROS1 inhibitor.

Rongchang Biology (09995): Tetaxip has been fully approved by China's National Drug Administration and can be used to treat adult patients with systemic lupus erythematosus.

R&F Real Estate (02777.HK): We are actively communicating and negotiating with relevant creditors.

Hong Kong Industrial International (00480.HK): Released interim results, net profit of HK$118 million, up 568.75% year on year.

Geely Automobile (00175.HK): Approximately 578.4 million shares were granted. The exercise price of the warrants was HK$9.56 per share.

2) Financing and repurchase news

China Eastern Airlines Co., Ltd. (006700.HK): Perpetual debt financing of RMB 20 billion was provided to China Eastern Airlines Group, the controlling shareholder.

China Life Insurance (02628.HK): It plans to issue capital supplementary bonds totaling no more than 35 billion yuan, depending on circumstances.

China Railway Construction (01186.HK): The registration application for the public issuance of corporate bonds to professional investors was approved by the China Securities Regulatory Commission.

Jiumaojiu (09922.HK): spent HK$10.859 million to repurchase 1.303 million shares at a repurchase price of HK$8.28-8.43.

COSCO Marine Holdings (01919.HK): spent HK$19.5888 million to repurchase 2.7 million shares at a repurchase price of HK$7.17-7.32.

Tencent Holdings (00700.HK): spent approximately HK$400 million to repurchase 1.23 million shares at a repurchase price of HK$322.20-329.80.

AIA (01299.HK): Invested approximately HK$135 million to repurchase 1,853,600 shares at a repurchase price of HK$71.90-73.00.

HSBC Holdings (00005.HK): spent HK$181 million to repurchase 2,9972 million shares at a repurchase price of HK$60.25-60.55.

China Petroleum & Chemical Co., Ltd. (00386.HK): Invested approximately HK$31.2525 million to repurchase 7.53 million shares at a repurchase price of HK$4.13-4.17.

Jinshan Software (03888.HK): spent HK$199815 million to repurchase 688,400 shares at a repurchase price of HK$28.95-29.1.

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment